Stevanato Group S.p.A. (“Stevanato” or the “Company”) investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Stevanato Group S.p.A. (NYSE: STVN), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Stevanato Group S.p.A. on November 3, 2026.

If you lost money on Stevanato Group S.p.A. securities, share your Stevanato Group S.p.A. loss information with the firm to learn about potentially pursuing a claim to recover your losses.

Stevanato Group S.p.A. investigation at a glance

  • Date of disclosure: November 3, 2026

  • Share price decline: $5.64 per share, or 28.57%

  • Closing price: $14.10 on November 3, 2026

What happened?

On November 3, 2026, Stevanato reported third quarter 2026 results, including, among other things, that GLP-1 revenue fell to roughly 17–18% of total company revenue, and the Company now expects low single-digit growth in 2027 amid lower GLP-1 syringe volumes “tied to one customer.”

On this news, Stevanato shares fell $5.64 or 28.57%, to close at $14.10 on November 3, 2026, thereby injuring investors.

“Stevanato Group S.p.A. shares dropped 28.57% after it was disclosed on November 3, 2026 that Stevanato reported that GLP-1 revenue fell to roughly 17–18% of total company revenue and that it now expected only low single-digit growth in 2027 amid lower GLP-1 syringe volumes “tied to one customer”. Our investigation will look at whether investors had complete and accurate information before that disclosure,” said Frank R. Cruz of The Law Offices of Frank R. Cruz.

What should Stevanato Group S.p.A. investors do now?

The Law Offices of Frank R. Cruz is investigating potential claims on behalf of Stevanato Group S.p.A. investors. Investors who lost money can visit the Stevanato Group S.p.A. investigation page, email info@frankcruzlaw.com, or call 310-914-5007.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

Questions and answers about the Stevanato Group S.p.A. investigation

Who is eligible? Investors who purchased Stevanato Group S.p.A. securities and suffered losses may have claims, and can contact the firm to find out whether the Stevanato Group S.p.A. investigation affects them.

What does a securities fraud investigation involve? In the Stevanato Group S.p.A. investigation, The Law Offices of Frank R. Cruz is examining whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.

Is there a lawsuit? This release announces an investigation by The Law Offices of Frank R. Cruz, not a lawsuit. If a securities class action is later filed against Stevanato Group S.p.A., investors may be able to seek appointment as lead plaintiff.

How are attorneys’ fees handled? The Law Offices of Frank R. Cruz works on contingency, so Stevanato Group S.p.A. investors pay no attorneys’ fees up front. Any attorneys’ fees and litigation expenses come only from a recovery, if there is one, and require court approval.

Information for whistleblowers

Anyone with non-public information about Stevanato Group S.p.A. should consider their options to assist the investigation or participate in the SEC Whistleblower Program. The program allows whistleblowers who provide original information leading to a successful SEC enforcement action to receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Frank R. Cruz at 310-914-5007 or email info@frankcruzlaw.com.

About The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process.

Prior results do not guarantee a similar outcome.

Related links

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Media gallery

About The Author